DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Kobelt G, Andlin-Sobocki P, Brophy S. et al.
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade(R)).
Rheumatology 2004;
43: 1158-1166
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.